3B Blackbio

{
  "main_header": {
    "sid": 418147,
    "name": "3B Blackbio",
    "stock_name": "3B Blackbio",
    "full_name": "3B Blackbio DX Ltd",
    "name_url": "stocks-analysis/3b-blackbio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,575.00",
    "chg": 49.8,
    "chgp": "3.27%",
    "dir": 1,
    "prev_price": "1,525.20",
    "mcapval": "1,330.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532067,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE994E01018",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "5.1 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/3b-blackbio-418147-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "3B Blackbio DX Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3817369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/3BBlackbioDXLtd_mojoScore_3817369.png",
        "date": "2026-02-03 08:14:34",
        "description": "3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 2 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, stagnant financial trends, and subdued quality scores, signalling caution for investors amid challenging market conditions."
      },
      {
        "title": "3B Blackbio DX Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3815328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/3BBlackbioDXLtd_technicaldot_3815328.png",
        "date": "2026-02-02 08:01:55",
        "description": "3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily moving averages and a 2.85% decline in share price, the stock’s longer-term indicators suggest a nuanced outlook for investors."
      },
      {
        "title": "3B Blackbio DX Ltd Gains 1.89%: Technical Momentum and Mixed Fundamentals Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-gains-189-technical-momentum-and-mixed-fundamentals-shape-week-3813185",
        "imagepath": "",
        "date": "2026-01-31 17:09:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Stock opens at Rs.1,590.20, down 2.83%</p>\n                    <p><strong>Jan 28:</strong> Strong rebound with 4.76% gain to Rs.1,665.90</p>\n                    <p><strong>Jan 29:</strong> Upgrade to Hold rating announced; stock dips 1.22%</p>\n                    <p><strong>Jan 30:</strong> Mild recovery with 1.33% gain to close at Rs.1,667.45</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,636.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,667.45</div><div..."
      },
      {
        "title": "3B Blackbio DX Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3808873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_mojoScore_3808873.png",
        "date": "2026-01-29 08:11:00",
        "description": "3B Blackbio DX Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold by MarketsMOJO as of 28 January 2026. This change reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company’s fundamentals remain mixed, improved technical indicators and a stable financial position have prompted a more cautious but optimistic stance."
      },
      {
        "title": "3B Blackbio DX Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-3808678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_technicaldot_3808678.png",
        "date": "2026-01-29 08:01:02",
        "description": "3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has demonstrated a notable shift in price momentum, reflected in its recent technical indicators and market performance. After a period of sideways movement, the stock is now exhibiting mildly bullish trends, supported by a combination of weekly bullish signals and mixed monthly technicals, suggesting a cautious but optimistic outlook for investors."
      },
      {
        "title": "3B Blackbio DX Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-3801399",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_mojoScore_3801399.png",
        "date": "2026-01-23 10:10:54",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 16 June 2025, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 23 January 2026, providing investors with the latest perspective on the stock’s performance and prospects."
      },
      {
        "title": "3B Blackbio DX Ltd Hits Intraday High with 7.21% Surge on 14 Jan 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-hits-intraday-high-with-721-surge-on-14-jan-2026-3792149",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_priceRelatedfactors_3792149.png",
        "date": "2026-01-14 14:16:56",
        "description": "3B Blackbio DX Ltd demonstrated robust intraday strength on 14 Jan 2026, surging to an intraday high of Rs 1,580, marking an 8.55% increase from its previous close. The stock outperformed its sector and broader market indices, reflecting notable trading momentum within the Healthcare Services sector."
      },
      {
        "title": "3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-technical-momentum-shifts-amid-mixed-market-signals-3791285",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_technicaldot_3791285.png",
        "date": "2026-01-14 08:01:18",
        "description": "3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent upgrade in price action, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the latest technical developments, contextualising them within the broader market environment and the company’s performance relative to the Sensex."
      },
      {
        "title": "3B Blackbio DX Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-3789841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_mojoScore_3789841.png",
        "date": "2026-01-12 10:10:03",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 262,
    "sid": "418147",
    "stock_news_url": "https://www.marketsmojo.com/news/3b-blackbio-dx-418147"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2025.",
      "datetime": "30-Jan-2026",
      "details": "3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Certificate under Reg.74(5) of SEBI (DP)Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Dec-2025",
      "details": "Special Window for Re-lodgement of Transfer Requests of Physical Shares",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "06 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "3B Blackbio DX Ltd has declared <strong>40%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

3B Blackbio DX Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-02-03 08:14:34

3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 2 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, stagnant financial trends, and subdued quality scores, signalling caution for investors amid challenging market conditions.

Read full news article

3B Blackbio DX Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-02-02 08:01:55

3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily moving averages and a 2.85% decline in share price, the stock’s longer-term indicators suggest a nuanced outlook for investors.

Read full news article

3B Blackbio DX Ltd Gains 1.89%: Technical Momentum and Mixed Fundamentals Shape Week

2026-01-31 17:09:53

Key Events This Week

Jan 27: Stock opens at Rs.1,590.20, down 2.83%

Jan 28: Strong rebound with 4.76% gain to Rs.1,665.90

Jan 29: Upgrade to Hold rating announced; stock dips 1.22%

Jan 30: Mild recovery with 1.33% gain to close at Rs.1,667.45

Week Open

Rs.1,636.55

Week Close

Rs.1,667.45

Read full news article

3B Blackbio DX Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-01-29 08:11:00

3B Blackbio DX Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold by MarketsMOJO as of 28 January 2026. This change reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company’s fundamentals remain mixed, improved technical indicators and a stable financial position have prompted a more cautious but optimistic stance.

Read full news article

3B Blackbio DX Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-29 08:01:02

3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has demonstrated a notable shift in price momentum, reflected in its recent technical indicators and market performance. After a period of sideways movement, the stock is now exhibiting mildly bullish trends, supported by a combination of weekly bullish signals and mixed monthly technicals, suggesting a cautious but optimistic outlook for investors.

Read full news article

3B Blackbio DX Ltd is Rated Sell

2026-01-23 10:10:54

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 16 June 2025, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 23 January 2026, providing investors with the latest perspective on the stock’s performance and prospects.

Read full news article

3B Blackbio DX Ltd Hits Intraday High with 7.21% Surge on 14 Jan 2026

2026-01-14 14:16:56

3B Blackbio DX Ltd demonstrated robust intraday strength on 14 Jan 2026, surging to an intraday high of Rs 1,580, marking an 8.55% increase from its previous close. The stock outperformed its sector and broader market indices, reflecting notable trading momentum within the Healthcare Services sector.

Read full news article

3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-14 08:01:18

3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent upgrade in price action, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the latest technical developments, contextualising them within the broader market environment and the company’s performance relative to the Sensex.

Read full news article

3B Blackbio DX Ltd is Rated Sell

2026-01-12 10:10:03

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News